Cullinan Therapeutics (CGEM) Other Working Capital Changes (2020 - 2026)

Cullinan Therapeutics' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at $662000.0 for Q1 2026.

• In Q1 2026, Other Working Capital Changes rose 138.0% year-over-year to $662000.0; the TTM figure through Mar 2026 stood at -$4.5 million (down 493.78% YoY), while the FY2025 annual figure was -$6.9 million, down 379.0% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at $662000.0, up from -$840000.0 in the prior quarter.
• The five-year high for Other Working Capital Changes was $3.8 million in Q3 2023, with the low at -$3.5 million in Q2 2025.
• The 5-year median for Other Working Capital Changes is -$90000.0 (2022), against an average of $194764.7.
• Peak annual rise in Other Working Capital Changes reached 801.84% in 2023, while the deepest fall reached 2028.89% in 2023.
• Cullinan Therapeutics' Other Working Capital Changes stood at $623000.0 in 2022, then soared by 428.73% to $3.3 million in 2023, then sank by 50.36% to $1.6 million in 2024, then sank by 151.38% to -$840000.0 in 2025, then surged by 178.81% to $662000.0 in 2026.
• Business Quant data shows CGEM's Other Working Capital Changes at $662000.0 in Q1 2026, -$840000.0 in Q4 2025, and -$798000.0 in Q3 2025.